Newsroom
July 20, 2026
Scientists at The University of Texas at San Antonio discovered a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
July 13, 2026
Amelie Ramirez, DrPH, MPH, director of the Institute for Health Promotion Research, chair, Department of Population Health Sciences at UT Health San Antonio, the academic health center and health system of The University of Texas at San Antonio, was quoted in this article. Read More
July 10, 2026
Hematology Advisor: New Insights Emerge for Tailored Survivorship Care Programs for Long-Term AML
June 25, 2026
Amelie G. Ramirez, DrPH, MPH, to work with Hispanics in South Texas Content provided by Cliff Despres Amelie G. Ramirez, DrPH, MPH, a cancer researcher at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, is receiving a two-year, $400,000 leadership grant from Susan G. Komen to study cancer survivorship. She aims […]
June 25, 2026
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual […]
June 25, 2026
A scientist at The University of Texas at San Antonio was recently awarded two grants totaling more than $4.6 million from the National Institutes of Health to study how cells repair DNA to protect the genome, the set of genetic instructions within our cells.
